For NZ residents only

NUCALA Pre-filled Pen2

Every 4 weeks. At home. On your time.

Injection for eosinophilic asthma
NUCALA Pre-filled pen is a 4-weekly injection for severe eosinophilic asthma patients ages 12 and older. Together, you and your doctor can decide if at-home administration with NUCALA is right for you.
Injection for eosinophilic asthma

Designed with you in mind

Don't like needles? With the NUCALA pre-filled pen, you don't have to see the needle.

In a study, after training by a healthcare provider4:

9
OUT
OF
10
patients found the pre-filled pen very or extremely easy to use.
99%
of patients successfully used the pre-filled pen.
For more information about injecting NUCALA at home, please see the full Instructions for Use.

At-home convenience4

After you learn how to properly self-inject from your doctor, you can do it on your own in the comfort of your own home with the NUCALA Pre-filled pen.
After training by a healthcare provider, 97% of patients in a study rated their confidence in using the pre-filled pen in the correct way, on their own and away from their doctors office as very or extremely confident.

Self-inject with confidence2

Once you and your specialist decide that the NUCALA Pre-filled pen is right for you, you will be given information on how to properly inject and how to monitor for allergic reactions. Sometimes, serious allergic reactions, including anaphylaxis, can occur hours or days later. Your NUCALA Pre-filled pen will arrive with full Instructions for Use.
list

Ready to talk to your doctor?

Download the doctor discussion guide to keep the conversation on track.
Important Safety Information:

Do not use NUCALA if you are allergic (hypersensitive) to mepolizumab or any of the ingredients in NUCALA.

Do not use to treat sudden breathing problems.

The most common side effects of NUCALA are headache, injection site reactions (pain, redness, swelling, itching, or a burning feeling at the injection site), back pain, and fatigue.

Tell your doctor or get emergency help right away if you think you are having an allergic reaction to NUCALA.

Any information provided on this website should be discussed with a healthcare professional and does not replace a healthcare professional's advice.

References:
  1. Data Sheet GlaxoSmithKline New Zealand. Nucala Data Sheet. GSK NZ; 2022. Available at http://www.medsafe.govt.nz/profs/datasheet/dsform.asp
  2. Consumer Medicine Information GlaxoSmithKline New Zealand. Nucala Consumer Medicine Information. GSK NZ; 2023. Available at https://www.medsafe.govt.nz/Medicines/infoSearch.asp
  3. Global Initiative for Asthma. Global Strategy for Asthma Management and Prevention 2022. Available from: www.ginasthma.org
  4. Bernstein D, Pavord ID, Chapman KR et al. Usability of mepolizumab single-use prefilled autoinjector for patient self-administration. J Asthma 2019;28:1-12
Nucala (mepolizumab 100 mg) is a Prescription Medicine, available as a 100 mg powder for injection (100 mg/ mL after reconstitution) and as a 100 mg/mL pre-filled pen (auto-injector). Nucala is used as an add-on treatment for; severe eosinophilic asthma in patients 12 years and over, severe chronic rhinosinusitis with nasal polyps (CRSwNP) with an inadequate response to intranasal corticosteroids in adult patients 18 years and older, relapsing or refractory Eosinophilic Granulomatosis with Polyangiitis (EGPA) in adult patients aged 18 years and over, and in adult patients with inadequately controlled hypereosinophilic syndrome (HES) without an identifiable non-haematologic secondary cause. Nucala is given by injection under your skin (subcutaneous). Nucala is fully funded for severe eosinophilic asthma only; Special Authority criteria apply. Use strictly as directed. Nucala has risks and benefits. Do not stop taking your other asthma medications including inhaled and /or oral steroid asthma medications. Tell your doctor if: you have a parasitic (helminth) infection; you are taking prescription and over-the-counter medicines, vitamins, and herbal supplements; you are pregnant or plan to become pregnant; you are breastfeeding or plan to breastfeed. Nucala does not treat acute asthma symptoms, such as sudden asthma attack. Tell your healthcare professional or get emergency help immediately if you have any of the following symptoms of an allergic reaction: swelling of your face, mouth, and tongue, breathing problems, fainting, dizziness, feeling light-headed (low blood pressure), rash or hives. Side effects: headache, injection site reactions (pain, redness, swelling, itching, or a burning feeling at the injection site), back pain, and fatigue. Serious side effects may include allergic (hypersensitivity) reactions, including anaphylaxis. Serious allergic reactions can happen after you get your injection of Nucala. Allergic reactions can sometimes happen hours or days after you get a dose of Nucala. Herpes zoster infections that can cause shingles have happened in people who received Nucala. If symptoms continue or you have side effects, see your doctor, pharmacist or health care professional. For more information, see Nucala Consumer Medicine Information at www.medsafe.govt.nz. Ask your doctor if Nucala is right for you. Normal doctor's charges apply.

This website is intended for residents of New Zealand only.